NCT02412098 Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function Status COMPLETED Phase PHASE1
NCT02405442 Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease Status TERMINATED Phase PHASE2
NCT02404792 Exercise for Healthy Aging: The Impact of HIV and Aging on Physical Function and the Somatopause Status COMPLETED Phase NA
NCT02404220 Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) Status TERMINATED Phase PHASE1/PHASE2
NCT02402452 Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment Status COMPLETED Phase PHASE1
NCT02400307 Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function Status COMPLETED Phase PHASE1
NCT02397707 Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment Status COMPLETED Phase PHASE1
NCT02397694 Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults Status COMPLETED Phase PHASE2
NCT02392611 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer Status COMPLETED Phase PHASE1
NCT02378961 Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection Status COMPLETED Phase PHASE2
NCT02378935 Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection Status COMPLETED Phase PHASE2
NCT02377336 GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease Status WITHDRAWN Phase PHASE2
NCT02367599 Effect of Vitamin D Supplementation on Bone Turnover Markers During PrEP in MSM Status COMPLETED Phase PHASE4
NCT02365532 Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults Status COMPLETED Phase PHASE1
NCT02365506 Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome Status COMPLETED Phase PHASE1
NCT02360397 Ranolazine Mediated PVC Reduction in Ischemic Heart Disease Status COMPLETED Phase PHASE2
NCT02357602 Dose Proportionality of TFV-DP After a Single Dose of GS-7340 in Women Status COMPLETED Phase PHASE1
NCT02350569 Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting Status COMPLETED Phase PHASE2
NCT02346721 Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection Status COMPLETED Phase PHASE3
NCT02345252 Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF) Status COMPLETED Phase PHASE3